Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
==================================================================================================================================================

* April A N Rose
* Susan M Armstrong
* David Hogg
* Marcus O Butler
* Samuel D Saibil
* Diana P Arteaga
* Thiago Pimentel Muniz
* Deirdre Kelly
* Danny Ghazarian
* Ian King
* Zaid Saeed Kamil
* Kendra Ross
* Anna Spreafico